Psykey, Inc. (OTCMKTS:CEOS) Short Interest Down 92.0% in July

Psykey, Inc. (OTCMKTS:CEOS) was the target of a large decrease in short interest in July. As of July 31st, there was short interest totaling 2,400 shares, a decrease of 92.0% from the July 15th total of 29,822 shares. Based on an average trading volume of 161,424 shares, the days-to-cover ratio is presently 0.0 days.

Psykey Stock Performance

Shares of CEOS remained flat at $0.01 during mid-day trading on Tuesday. The stock had a trading volume of 2,200 shares, compared to its average volume of 180,128. Psykey has a fifty-two week low of $0.00 and a fifty-two week high of $0.01. The firm’s 50-day moving average price is $0.01 and its 200 day moving average price is $0.01.

Psykey Company Profile

Psykey, Inc engages in the research, development, and commercialization of entheogenic, adaptogenic, and nootropic ingredients and formulations for its functional product lines to improve and optimize life. The company also engages in the development of technologies for the composition, bioavailability, and targeted delivery of entheogen-based therapeutics for the psychedelic market. Its retail products include functional mushroom coffees and teas, oral supplements, and single serve drink mixes. The company was formerly known as CeCors, Inc and changed its name to Psykey, Inc in August 2021.